[go: up one dir, main page]

FR2280376A1 - Nouveaux derives du piperidine-4 ethanol - Google Patents

Nouveaux derives du piperidine-4 ethanol

Info

Publication number
FR2280376A1
FR2280376A1 FR7426849A FR7426849A FR2280376A1 FR 2280376 A1 FR2280376 A1 FR 2280376A1 FR 7426849 A FR7426849 A FR 7426849A FR 7426849 A FR7426849 A FR 7426849A FR 2280376 A1 FR2280376 A1 FR 2280376A1
Authority
FR
France
Prior art keywords
ethanols
piperidin
sedative
effects
low incidence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7426849A
Other languages
English (en)
Other versions
FR2280376B1 (fr
Inventor
Claude Gueremy
Quy Nguyen-Huu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOGERAS
Original Assignee
SOGERAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOGERAS filed Critical SOGERAS
Priority to FR7426849A priority Critical patent/FR2280376A1/fr
Priority to BE158863A priority patent/BE832036A/fr
Publication of FR2280376A1 publication Critical patent/FR2280376A1/fr
Application granted granted Critical
Publication of FR2280376B1 publication Critical patent/FR2280376B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7426849A 1974-08-02 1974-08-02 Nouveaux derives du piperidine-4 ethanol Granted FR2280376A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7426849A FR2280376A1 (fr) 1974-08-02 1974-08-02 Nouveaux derives du piperidine-4 ethanol
BE158863A BE832036A (fr) 1974-08-02 1975-08-01 Nouveaux derives du piperidine-4 ethanol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7426849A FR2280376A1 (fr) 1974-08-02 1974-08-02 Nouveaux derives du piperidine-4 ethanol

Publications (2)

Publication Number Publication Date
FR2280376A1 true FR2280376A1 (fr) 1976-02-27
FR2280376B1 FR2280376B1 (fr) 1978-07-21

Family

ID=9142025

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7426849A Granted FR2280376A1 (fr) 1974-08-02 1974-08-02 Nouveaux derives du piperidine-4 ethanol

Country Status (2)

Country Link
BE (1) BE832036A (fr)
FR (1) FR2280376A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005795A1 (fr) * 1987-12-23 1989-06-29 Aktiebolaget Hässle Nouveaux agents antiarythmiques ii

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005795A1 (fr) * 1987-12-23 1989-06-29 Aktiebolaget Hässle Nouveaux agents antiarythmiques ii
WO1989005806A1 (fr) * 1987-12-23 1989-06-29 Ab Hässle Nouveaux agents antiarythmiques iii
US5034411A (en) * 1987-12-23 1991-07-23 Aktiebolaget Hassle Novel 4-cyanophenyl derivatives with action against cardiac arrhythmia

Also Published As

Publication number Publication date
FR2280376B1 (fr) 1978-07-21
BE832036A (fr) 1975-12-01

Similar Documents

Publication Publication Date Title
ES435273A1 (es) Un procedimiento de preparacion de n-(1-bencil-pirrolidi- nil-2-alcohil) -benzamidas sustituidas.
GB1334138A (en) Immunological adjuvatns
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
ES425514A1 (es) Un procedimiento para la preparacion de nuevas 3-nitrocuma-rinas.
FR2280376A1 (fr) Nouveaux derives du piperidine-4 ethanol
ES434242A1 (es) Un procedimiento para la preparacion de nuevos derivados pi-peridinicos tetraciclicos.
ES413153A1 (es) Un procedimiento para la preparacion de anilino benzotia- zoles.
ES411112A1 (es) Procedimiento de preparacion de nuevos derivados del 1'1- difenil-etileno.
ES382051A1 (es) Procedimiento para la preparacion de nuevos esteres y ami- das de acido n-((3-trifluorometilfenil) - antraniloil) - glicolico.
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
ES391993A1 (es) Procedimiento para la preparacion de derivados de teofilina
GB1412617A (en) Substituted aryl and aralkyl amides
GB1489992A (en) Use of antibiotics of the streptothricin family as taeniacidal agents
JPS5373406A (en) Quenching media for steel
ES400414A1 (es) Procedimiento para la preparacion de derivados de piperidi-na n-sustituidos y su utilizacion como estabilizadores.
ES420665A1 (es) Procedimiento para preparar 7 alfa-ciano-espirolactonas es- teroidales.
FR2294701A1 (fr) Inhibiteurs de beta-lactamase et procede pour leur preparation
ES385521A1 (es) Un metodo para producir un compuesto de azamorfinano.
GB1176049A (en) N-Substituted Noratropinium Salts
ES402640A1 (es) Procedimiento para la preparacion de nuevos esteres alcohi-licos de acido tiolcarbamidico basicamente sustituidos.
FR2290203B1 (fr)
ES402285A1 (es) Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica.
FR2137626A1 (en) 6-(benzazepine-6-yl) benzoic acid salts-intermediates for - rheadan alkaloids
ES372066A1 (es) Un procedimiento de preparacion de lactonas omega-sustitui-das.
ES346853A3 (es) Un metodo para reducir el elevado nivel de colesterol en lasangre.

Legal Events

Date Code Title Description
ST Notification of lapse